Arrhythmia drug tied to cancer risk in men in population study

04/8/2013 | MedPage Today (free registration)

An analysis of data from a health database in Taiwan found that men who took the antiarrhythmia drug amiodarone had a nearly 20% increased risk of developing cancer compared with the general population. The risk was 46% greater among men with extensive exposure to the drug. Women, however, did not seem to have a higher risk, researchers reported in the journal Cancer.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI